Sign in
4

Changes in Ownership

Syndax Pharmaceuticals Inc Filed Acc 0001562180-23-005152

Chief Financial Officer sold 577 shares at $22.31 ($12,873)

From the SEC's structured data for this filing

Trades in this filing

Goldan Keith A. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-06-13 Sale : show line 1 in the form −577 $22.31 $12,873 2,628 D
Open-market sales · 577 sh · avg $22.31 · $12,873
Loading xslF345X04/primarydocument.xml…